Danielle Magness-Wellmann, DO
Psychiatry · Mankato, MNNPI 1679729164
Payments from drug & device makers
Across 455 payments — averaging $677.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$76K
- AbbVie$64K
- Axsome Therapeutics, Inc.$56K
- Otsuka America Pharmaceutical, Inc.$45K
- Teva Pharmaceuticals USA, Inc.$29K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$22K
- plus $16K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 9 | $75,704 |
| AbbVie(2 entities) | 108 | $64,420 |
| Axsome Therapeutics, Inc. | 77 | $56,457 |
| Otsuka America Pharmaceutical, Inc. | 86 | $44,975 |
| Teva Pharmaceuticals USA, Inc. | 53 | $28,933 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $21,725 |
| Tris Pharma Inc | 13 | $7,195 |
| Biogen | 4 | $6,684 |
| Sunovion Pharmaceuticals Inc. | 12 | $1,187 |
| Supernus Pharmaceuticals, Inc. | 6 | $120 |
| Acadia Pharmaceuticals Inc | 7 | $112 |
| Corium, LLC | 12 | $110 |
| Ironshore Pharmaceuticals Inc. | 7 | $97 |
| Harmony Biosciences LLC | 4 | $96 |
| Vanda Pharmaceuticals Inc. | 4 | $71 |
| Alkermes, Inc. | 5 | $63 |
| Almatica Pharma LLC | 3 | $40 |
| Sage Therapeutics, LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Eisai Inc. | 2 | $30 |
| Indivior Inc. | 1 | $20 |
| Novo Nordisk | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$308,163 in reported general payments places this provider in the 95th percentile of 552 psychiatry providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Mankato
- Michael FarnsworthMankato$548K
- Edward SathoffMankato$1K
- Robert OlsonMankato$1K
- Veronica RadiganMankato$496
- Ziad NahasMinneapolis$732K
- Sujit VarmaEdina$581K
- John LuehrMinnetonka$154K
- Craig VineSt Paul$136K
- Alik WidgeMinneapolis$96K
- Thomas WinegardenChanhassen$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.